Report for Lee JI

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus - Baek_2022_Signal.Transduct.Target.Ther_7_367
Author(s) : Baek YB , Kwon HJ , Sharif M , Lim J , Lee IC , Ryu YB , Lee JI , Kim JS , Lee YS , Kim DH , Park SI , Kim DK , Choy HE , Lee S , Choi HS , Osborne TF , Jeon TI , Cho KO
Ref : Signal Transduct Target Ther , 7 :367 , 2022
Abstract : Baek_2022_Signal.Transduct.Target.Ther_7_367
ESTHER : Baek_2022_Signal.Transduct.Target.Ther_7_367
PubMedSearch : Baek_2022_Signal.Transduct.Target.Ther_7_367
PubMedID: 36253361

Title : Pharmacokinetics and safety of evogliptin in hepatically impaired patients - Hong_2021_Br.J.Clin.Pharmacol_87_2757
Author(s) : Hong T , Jin BH , Kim CO , Yoo BW , Kim D , Lee JI , Kim BK , Ahn SH , Kim DY , Park JY , Park MS
Ref : British Journal of Clinical Pharmacology , 87 :2757 , 2021
Abstract : Hong_2021_Br.J.Clin.Pharmacol_87_2757
ESTHER : Hong_2021_Br.J.Clin.Pharmacol_87_2757
PubMedSearch : Hong_2021_Br.J.Clin.Pharmacol_87_2757
PubMedID: 33245796